| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.32 | 2e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.31 | 3e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |